Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat

Journal of Neuroscience

Volumn 22, Issue 16, 2002, Pages 7272-7280

  Pillot, Catherine ^a   Ortiz, Jordi ^a   Héron, Anne ^a   Ridray, Sophie ^a   Schwartz, Jean Charles ^b   Arrang, Jean Michel ^b  

^a Laboratoire des Sciences Vegetales   (France)

^b INSERM   (France)

Author keywords

Antagonist inverse agonist; c fos; Catalepsy; Ciproxifan; D2 receptor; Enkephalin; H3 receptor; Haloperidol; Histamine; In situ hybridization; Locomotor activity; Neurotensin

Indexed keywords

ALPHA METHYLHISTAMINE; CIPROXIFAN; DOPAMINE 2 RECEPTOR; HALOPERIDOL; HISTAMINE H3 RECEPTOR; MESSENGER RNA; 4 AMINOBUTYRIC ACID; ANTIHISTAMINIC AGENT; ENKEPHALIN; IMIDAZOLE DERIVATIVE; LIGAND; NEUROTENSIN; PROENKEPHALIN; PROTEIN C FOS; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG POTENTIATION; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT; ANIMAL; ANIMAL BEHAVIOR; AUTORADIOGRAPHY; BIOSYNTHESIS; BRAIN LEVEL; CHEMICALLY INDUCED DISORDER; CORPUS STRIATUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; MOTOR ACTIVITY; NERVE CELL; UPREGULATION; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CATALEPSY; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENKEPHALINS; GAMMA-AMINOBUTYRIC ACID; HALOPERIDOL; HISTAMINE ANTAGONISTS; IMIDAZOLES; IN SITU HYBRIDIZATION; LIGANDS; MALE; MOTOR ACTIVITY; NEURONS; NEUROTENSIN; PROTEIN PRECURSORS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H3; RNA, MESSENGER; UP-REGULATION;

EID: 0037101814     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-16-07272.2002     Document Type: Article

References (87)

1. Albin RL, Young AB, Penney JB (1989) The functional neuroanatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
2. Albin RL, Young AB, Penney JB (1995) The functional anatomy of disorders of the basal ganglia. Trends Neurosci 18:63-64.
3. Alburges ME, Keefe KA, Hanson GR (2001) Contrasting responses by basal ganglia met-enkephalin systems to low and high doses of methamphetamine in a rat model. J Neurochem 76:721-729.
4. 2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J Neurochem 58:1104-1109.
5. Angulo JA, McEwen BS (1994) Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res Rev 19:1-28.
6. Angulo JA, Cadet JL, Woolley CS, Suber F, McEwen BS (1990) Effect of chronic typical and atypical neuroleptic treatment on proenkephalin mRNA levels in the striatum and nucleus accumbens of the rat. J Neurochem 54:1889-1894.
7. 3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci 12:3823-3832.
8. 3 receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease. Neurobiol Dis 8:707-716.
9. 3H]-γ-aminobutyric acid from rat striatal slices. Br J Pharmacol 133:165-171.
10. 3) of histamine receptor. Nature 302:832-837.
11. 3-receptors. Nature 327:117-123.
12. Bacciottini L, Passani MB, Mannaioni PF, Blandina P (2001) Interactions between histaminergic and cholinergic systems in learning and memory. Behav Brain Res 124:183-194.
13. 3H]histamine in rat brain. Mol Pharmacol 18:1-10.
14. 3 Receptor (Leurs R, Timmermann H, eds), pp 27-40. Amsterdam: Elsevier.
15. Bordet R, Ridray S, Schwartz JC, Sokoloff P (2000) Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats. Eur J Neurosci 12:2117-2123.
16. Brown RE, Stevens DR, Haas HL (2001) The physiology of brain histamine. Prog Neurobiol 63:637-672.
17. Bristow LJ, Bennett GW (1988) Biphasic effects of intra-accumbens histamine administration on spontaneous motor activity in the rat: A role for central histamine receptors. Br J Pharmacol 95:1292-1302.
18. Carlsson A (1993) On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity. J Neural Trans 40:1-12.
19. Carlsson A, Hansson LO, Waters N, Carlsson ML (1997) Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications. Life Sci 61:75-94.
20. Castel MN, Morino P, Dagerlind A, Hökfelt (1994) Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. Eur J Neurosci 6:646-656.
21. Chiavegatto S, Nasello AG, Bernardi MM (1998) Histamine and spontaneous motor activity: Biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci 62:1875-1888.
22. 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 259:107-114.
23. 35S]GTPγ[S] binding to pertussis toxin. Eur J Pharmacol 296:223-225.
24. 3 receptor: Characterization and autoradiographic localization in rat brain. Synapse 8:144-151.
25. Deutch AY, Lee MC, Iadarola MJ (1992) Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci 3:332-341.
26. 2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience 37:287-294.
27. 3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59:1-8.
28. 2 receptors as a major mechanism for the neuroleptic-like action of neurotensin. Ann NY Acad Sci 668:186-204.
29. 3H]-γ-aminobutyric acid release from depolarisation-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 80:241-249.
30. Gerfen CR (1992) The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15:285-320.
31. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432.
32. 3-receptor binding in the normal human basal ganglia: Comparison with Huntington's and Parkinson's disease cases. Eur J Neurosci 11:449-456.
33. Hauber W (1998) Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 56:507-540.
34. Heimer L, Alheid GF, Zaborsky L (1985) Basal ganglia. In: The Rat Nervous System, Vol 1, Forebrain and Midbrain (Paxinos G, ed), pp 37-86. New York: Academic.
35. 3 receptor in developing rat tissues. Mech Dev 105:167-173.
36. 3-receptor antagonist, in a light dark test measuring anxiety in mice. Life Sci 53:1675-1683.
37. 1 receptors. Proc Natl Acad Sci USA 93:13316-13320.
38. Ito C, Onodera K, Sakurai E, Sato M, Watanabe T (1996) Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatments with methamphetamine. J Pharmacol Exp Ther 279:271-276.
39. Ito C, Onodera K, Watanabe T, Sato M (1997) Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats. Psychopharmacology 130:362-367.
40. Itoh Y, Nishibori M, Oishi R, Saeki K (1984) Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice. Neurosci Lett 48:305-309.
41. Kalivas PW (1982) Histamine induced arousal in the conscious and pentobarbital rat. J Pharmacol Exp Ther 222:37-42.
42. Le Moine C, Bloch B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426.
43. 3-receptor antagonist. J Pharmacol Exp Ther 287:658-666.
44. 3 receptor. Mol Pharmacol 55:1101-1107.
45. 3 receptor reveals distinct species pharmacological profiles. J Pharmacol Exp Ther 293:771-778.
46. 3) visualized in the brain of human and non-human primates. Brain Res 526:322-327.
47. Merchant KM (1994) c-fos Antisense oligonucleotide specifically attenuates haloperidol-induced increases in the neurotensin-neuromedin N mRNA expression in the dorsal striatum. Mol Cell Neurosci 5:336-344.
48. Merchant KM, Dorsa DM (1993) Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc Natl Acad Sci USA 90:3447-3451.
49. Merchant KM, Miller MA (1994) Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol. Mol Brain Res 23:271-277.
50. Merchant KM, Dobner PR, Dorsa DM (1992) Differential effects of haloperidol and clozapine on neurotensin gene transcription in rat neostriatum. J Neurosci 12:652-663.
51. 3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice. Life Sci 61:355-361.
52. 3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology 41:928-934.
53. Morgan JI, Curran T (1991) Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenesfos and jun. Annu Rev Neurosci 14:421-451.
54. 2A receptor blockade. J Pharmacol Exp Ther 288:590-596.
55. 3 receptors regulates histamine neurons in brain. Nature 408:860-864.
56. 3 receptor: Gene organization and multiple isoforms. Biochem Biophys Res Commun 280:75-80.
57. 3 receptor. J Pharmacol Exp Ther 300:621-628.
58. 2 antagonists. Neuroscience 25:525-532.
59. Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA 89:4270-4274.
60. Nistico G, Rotiroti D, De Sarro A, Naccari F, Stephenson JD (1980) Central effects of histamine and H1 and H2 receptor agonists and antagonists after intraventricular infusion in fowls. Res Commun Chem Pathol Pharmacol 27:431-450.
61. 3 receptors? Eur J Pharmacol 184:135-142.
62. Onodera K, Yamatodani A, Watanabe T, Wada H (1994) Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders. Prog Neurobiol 42:685-702.
63. Parent A, Harati LN (1995) Functional anatomy of the basal ganglia. I. The cortical-basal ganglia-thalamo-cortical loop. Brain Res Rev 20:91-127.
64. 3 receptor and its gene transcripts in rat brain. Neuroscience, in press.
65. 3 receptors in rat brain areas. Neuroscience 52:169-189.
66. Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, Linnoila M, Wyatt RJ (1995) Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: Their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14:93-104.
67. Reiner A, Anderson K (1990) The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: Conclusions based on recent findings. Brain Res Rev 15:251-265.
68. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49:285-296.
69. Romano GJ, Shivers BD, Harlan RE, Howells RD, Pfaff DW (1987) Haloperidol increases proenkephalin mRNA levels in the caudateputamen of the rat: A quantitative study at the cellular level using in situ hybridization. Mol Brain Res 2:33-41.
70. 3 receptors. Br J Pharmacol 135:383-392.
71. 2 receptors in rat brain. NeuroReport 5:621-624.
72. 3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons: An autoradiographic study. Neurosci Lett 178:19-22.
73. Ryu JH, Yanai K, Sakurai E, Kim CY, Watanabe T (1995) Ontogenetic development of histamine receptor subtypes in rat brain demonstrated by quantitative autoradiography. Dev Brain Res 87:101-110.
74. 3-receptors following destruction of the ascending dopaminergic neurones. Br J Pharmacol 118:585-592.
75. Sakai N, Onodera K, Maeyama K, Yanai K, Watanabe T (1992) Effects of α-fluoromethylhistidine and metoprine on locomotor activity and brain histamine contents in mice. Life Sci 51:397-405.
76. 3 heteroreceptors. Fund Clin Pharmacol 8:128-137.
77. Schwartz JC, Arrang JM (2002) Histamine. In: Neuropsychopharmacology: The Fifth Generation of Progress (Davis KL, Charney D, Coyle JT, Nemeroff C, eds), pp 179-190. Philadelphia: Lippincott Williams and Wilkins.
78. Sonnenberg JL, Rauscher FJ III, Morgan JI, Curran T (1990) Regulation of proenkephalin by Fos and Jun. Science 246:1622-1625.
79. Sugimoto T, Mizuno N (1987) Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: An immunohistochemical study in the cat. J Comp Neurol 257:383-395.
80. Svensson A, Carlsson ML, Carlsson A (1995) Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice, J Neural Transm Gen Sect 101:127-148.
81. Takeshita Y, Watanabe T, Sakata T, Munakata M, Ishibashi H, Akaike N (1998) Histamine modulates high-voltage-activated calcium channels in neurons dissociated from the rat tuberomammillary nucleus. Neuroscience 87:797-805.
82. Tang F, Costa E, Schwartz JP (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc Natl Acad Sci USA 80:3841-3844.
83. 3 receptor: Evidence for two isoforms. NeuroReport 11:755-759.
84. Tuomisto L, Eriksson L (1980) Cardiovascular and behavioural changes after i.c.v. infusions of histamine and agonists in conscious goat. Agents Actions 10:165-166.
85. 2 receptors. Trends Pharmacol Sci 10:74-77.
86. 2 interactions by muscarinic receptors. J Pharmacol Exp Ther 281:972-982.
87. Yanai K, Son LZ, Endou M, Sakurai E, Nakagawasai O, Tadano T, Kisara K, Inoue I, Watanabe T, Watanabe T (1998) Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience 87:479-487.